1 active not recruiting, 1 completed, 1 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow erucylphosphocholine: new trials by email Literature Review of erucylphosphocholine trials Research Report on erucylphosphocholine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Maternal Health Multilevel Intervention for Racial Equity (MIRACLE) Project Multilevel intervention for racial disparities in severe maternal morbidity and mortality, Standard Enhanced Prenatal Care (EPC) services - Maternal Morbidity and Mortality, Health Disparities | Not applicable | Active not recruiting | Michigan State University | 540000 | 2022-01-01 | 2026-11-02 |
| PCSK9 Inhibitors in the Progression of Aortic Stenosis PCSK9 Inhibitor [EPC], Placebos - Aortic Valve Stenosis | Phase 2 | Unknown | Seoul National University Hospital | 140 | 2017-06-01 | 2017-02-13 |
| Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry PCSK9 Inhibitor [EPC], Standard lipid lowering therapy - Dyslipoproteinemias, Hypercholesterolemia, Familial | Completed | GWT-TUD GmbH | 1695 | 2017-05-18 | 2025-05-09 |
Aortic Valve Stenosis (1) · Dyslipidemias (1) · Homozygous Familial Hypercholesterolemia (1) · Hyperlipidemia, Familial Combined (1) · Hyperlipoproteinemia Type II (1) · Maternal Death (1)
GWT-TUD GmbH (1) · Michigan State University (1) · Seoul National University Hospital (1)
Germany (1) · South Korea (1) · United States (1)
Andreas Birkenfeld, MD, PhD (1) · Bernd Hohenstein, MD, PhD (1) · Cristian Meghea, PhD (1) · David Pittrow, MD, PhD (1) · Elisabeth Steinhagen-Thiessen, MD, PhD (1) · Jennifer E Johnson, PhD (1) · Klaus G Parhofer, MD, PhD (1) · Ulrich Laufs, MD, PhD (1) · Volker JJ Schettler, MD, PhD (1)